Goldman Sachs Group Inc Abiomed Inc Transaction History

Goldman Sachs Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 14, 2024	BUY	$242.49 - $301.46 $783,242 - $973,715	3,230 Added 2.61%	127,056 $31.2 Million
Q3 2022 Nov 10, 2022	BUY	$242.49 - $301.46 $783,242 - $973,715	3,230 Added 2.61%	127,056 $31.2 Million
Q2 2022 May 14, 2024	BUY	$224.73 - $338.64 $27.8 Million - $41.9 Million	123,826 New	123,826 $30.6 Million
Q2 2022 Aug 15, 2022	BUY	$224.73 - $338.64 $1.58 Million - $2.38 Million	7,038 Added 6.03%	123,826 $30.6 Million
Q1 2022 May 16, 2022	SELL	$277.25 - $366.29 $23,011 - $30,402	-83 Reduced 0.07%	116,788 $38.7 Million
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $4.15 Million - $5.13 Million	-13,820 Reduced 10.57%	116,871 $42 Million
Q3 2021 Nov 10, 2021	BUY	$310.19 - $376.2 $40.5 Million - $49.2 Million	130,691 New	130,691 $42.5 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.